Rod Raynovich is a trader and analyst with a focus on healthcare and macro trends.

His WEB site at www.raygent.com also covers macro trends in energy, real estate and interest rates. Mr. Raynovich has extensive expertise in healthcare technology and provides business development consulting to early stage companies in biotechnology, diagnostics and imaging.

The Rayno Life Science Portfolio was published on raygent.com and in the trade magazine

www.genengnews.com.

Articles have been published on the following topics: Alzheimer Disease,Genomics,Molecular Diagnostics, Personalized Medicine, H1N1 and Government Policy on biotechnology.

The Life Science Portfolio is up about 8% at mid-August 2009 and among the biotech winners are ABAX, AMGN, ILMN, IMA, HOLX, ISIS, MITI, RDEA,REGN, TRGT, and UTHR.